Strategic Clinical Development  SRxA's in-house experts and clinical advisors can help you with your clinical development programs. Our understanding of the markets in which you operate along with the clinical expertise of our Advisors, make us uniquely capable of helping you develop clinical studies that incorporate appropriate health outcomes to bridge identified gaps in knowledge, compliance, and/or cost-efficacy.
Contact us to see how we can help you with:
- Surveys and questionnaires
- Retrospective Data Analysis
- Protocol Design
- Protocol Review
- Case record form (CRF) design
- Investigator meetings
- FDA support
- Preparation of independent review board (IRB) submissions
- Prospective Phase III studies
- Post-Marketing Surveillance / Pharmacovigilance (Phase IV) studies
- Evidence Based Reviews
- Meta-analyses
- Biostatistics
- Medical reports
- Preparation of abstracts, posters, manuscripts
- Development of enduring materials originating from clinical research
Some of the many advantages of working with SRxA include:
- Separation of science and sponsor
- Quick Identification of appropriate, experienced investigators and study sites
- SRxA advisors are always available as investigators
- Peer-to-peer recruitment of additional investigators
- Faster initiation / quicker enrolment / lower costs
SRxA is not a Clinical Research Organization (CRO), so studies can be monitored by your in-house team, a preferred CRO, or SRxA will suggest a CRO for you.
|
What we do